Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tumorigenic pathways in low-stage bladder cancer based on p53, MDM2 and p21 phenotypes.

The Journal of urology - 1 May 2001

Droller M J

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Transformation, Neoplastic
Share to Cyclin-Dependent Kinase Inhibitor p21
Share to Cyclins
Share to Neoplasm Proteins

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Proto-Oncogene Proteins

Share to Proto-Oncogene Proteins c-mdm2

Share to Tumor Suppressor Protein p53

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 11345951
DOI: 10.1016/s0022-5347(05)66418-x

Genes

MDM2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tumorigenic pathways in low-stage bladder cancer based on p53, MDM2 and p21 phenotypes.PMID 11345951Read ↗

Tumorigenic pathways in low-stage bladder cancer based on p53, MDM2 and p21 phenotypes.Semantic proximity Read ↗

Genetic alterations and biological pathways in human bladder cancer pathogenesisSemantic proximity Read ↗

Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity.Semantic proximity Read ↗

Morphologic and Molecular Characteristics of Bladder Cancer.Semantic proximity Read ↗

Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancerSemantic proximity Read ↗

Molecular profile of bladder cancer progression to clinically aggressive subtypesSemantic proximity Read ↗

Molecular pathogenesis of bladder cancer.Semantic proximity Read ↗

Molecular genetics of bladder cancer: pathways of development and progression.Semantic proximity Read ↗

Molecular pathogenesis of urothelial carcinoma: the clinical utility of emerging new biomarkers and future molecular classification of bladder cancer.Semantic proximity Read ↗

Update on bladder cancer molecular subtypesSemantic proximity Read ↗

miRNAs role in bladder cancer pathogenesis and targeted therapy: Signaling pathways interplay – A reviewSemantic proximity Read ↗

Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.